These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 2545335
1. Dipyridamole enhancement of etoposide sensitivity. Howell SB, Hom DK, Sanga R, Vick JS, Chan TC. Cancer Res; 1989 Aug 01; 49(15):4147-53. PubMed ID: 2545335 [Abstract] [Full Text] [Related]
2. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole. Howell SB, Hom D, Sanga R, Vick JS, Abramson IS. Cancer Res; 1989 Jun 15; 49(12):3178-83. PubMed ID: 2720673 [Abstract] [Full Text] [Related]
3. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Shalinsky DR, Andreeff M, Howell SB. Cancer Res; 1990 Dec 01; 50(23):7537-43. PubMed ID: 1979245 [Abstract] [Full Text] [Related]
4. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro. Jekunen A, Vick J, Sanga R, Chan TC, Howell SB. Cancer Res; 1992 Jul 01; 52(13):3566-71. PubMed ID: 1617625 [Abstract] [Full Text] [Related]
5. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro. Maca RD. Anticancer Drug Des; 1991 Nov 01; 6(5):453-66. PubMed ID: 1722410 [Abstract] [Full Text] [Related]
6. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells. Tatsuta T, Shimizu K, Nishimura T, Suzuki H. Anticancer Drug Des; 1991 Jul 01; 6(3):179-88. PubMed ID: 1678605 [Abstract] [Full Text] [Related]
7. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM, Sinha BK. Mol Pharmacol; 1989 Mar 01; 35(3):271-8. PubMed ID: 2564628 [Abstract] [Full Text] [Related]
8. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts. White JC, Hines LH, Rathmell JP. Cancer Res; 1985 Jul 01; 45(7):3070-5. PubMed ID: 4005845 [Abstract] [Full Text] [Related]
17. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux. Chan TC. Cancer Res; 1989 May 15; 49(10):2656-60. PubMed ID: 2713849 [Abstract] [Full Text] [Related]
18. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate. Plagemann PG. J Cell Physiol; 1986 Sep 15; 128(3):491-500. PubMed ID: 3488996 [Abstract] [Full Text] [Related]
19. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport. Chen HX, Bamberger U, Heckel A, Guo X, Cheng YC. Cancer Res; 1993 May 01; 53(9):1974-7. PubMed ID: 8097671 [Abstract] [Full Text] [Related]